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ABSTRACT
Depression is associated with poor antiretroviral therapy (ART) adherence among people living with
HIV/AIDS. This relationship may be moderated by an individual’s social network characteristics. Our
study sought to examine social network correlates of treatment adherence among HIV-positive men
recruited from social service agencies throughout Los Angeles County (N = 150) to inform
technology-driven social support interventions for this population. We administered egocentric
social network and computer-assisted survey interviews focused on demographic characteristics,
health history, depressive symptoms, and ART adherence, where adherence was assessed by the
number of reasons participants missed taking their medication, if ever. Significant univariate
correlates of adherence were included in a multivariable regression analysis, where the
moderating effect of having a network member who reminds participants to take their HIV
medication on the relationship between depression and adherence was tested. Over 60% of
participants reported clinically significant depressive symptoms; this was significantly associated
with lower adherence among those without someone in their social network to remind them
about taking their HIV medication, even after adjusting for covariates in an ordinary least
squares regression (adjusted mean difference b =−1.61, SE = 0.42, p = 0.0003). Having a network
member who reminds participants to take their ART medication significantly ameliorated the
negative association between depression and treatment adherence, especially for those
reporting greater depressive symptoms (p = 0.0394). Additionally, participants demonstrated high
rates of technology use to communicate with social network members. In order to achieve the
aims of the National HIV/AIDS Strategy, innovative interventions addressing mental health to
improve ART adherence are needed. Network strategies that leverage technology may be helpful
for improving ART adherence among HIV-positive men with comorbid depressive symptoms.
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Introduction
Men who have sex with men (MSM) account for nearly
three-quarters of all new HIV diagnoses among men in
the United States (Centers for Disease Control and Pre-
vention, 2015). The National HIV/AIDS Strategy aims to
increase access to care, improve health outcomes for
people living with HIV, and reduce HIV-related dispar-
ities (White House Office of National AIDS Policy,
2015). Treatment adherence for HIV-positive people is
key to maintaining viral suppression, reducing drug
resistance, improving overall health and wellbeing, and
reducing transmission risk to others (Chesney, 2006;
Cohen et al., 2011; World Health Organization, 2003).
In California, recent data indicate that 60% of HIV-posi-
tive MSM have achieved viral suppression; this percen-
tage is lower for MSM of color (California Department
of Public Health Office of AIDS, 2014).
Patient-level barriers to adherence have been ident-
ified in previous research, including depression and
low levels of social support. Gonzalez and colleagues
found depression was significantly associated with treat-
ment non-adherence, which was consistent over time,
across samples, and inclusive of those who were clinically
depressed as well as those who self-reported depressive
symptoms (Gonzalez, Batchelder, Psaros, & Safren,
2011). However, supportive social support networks
increase use of primary care and consistent medication
adherence among HIV-positive individuals (Hamilton,
Razzano, & Martin, 2007; Ramaswamy et al., 2013).
For example, Reich and colleagues found that having
positive support from one or more “important” persons
within one’s social network produced better mental
health outcomes (Reich, Lounsbury, Zaid-Muhammad,
& Rapkin, 2010).
Technology use among HIV-positive individuals has
been studied as a tool for treatment adherence interven-
tions. Multiple studies have examined text messaging
through cell phones, online social networking sites, and
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chat rooms (Fox, 2011; Lester et al., 2009; Rhodes et al.,
2010). A study involving HIV-positive individuals found
76% used online social networking and participants who
owned a mobile phone were found to report better ART
adherence (Horvath et al., 2012). These studies exemplify
opportunities to leverage mobile technologies to meet the
social networking needs of and improve ART treatment
adherence for HIV-positive people.
Conceptual framework
Theories of social support offer an understanding of
human relationships and the effects they have on stress-
ful situations (Callaghan & Morrissey, 1993; Cohen &
McKay, 1984; Cohen &Wills, 1985). The buffering effect
of social support theory supposes that social networks
can attenuate the negative effects of chronic stress
(Cohen & McKay, 1984). Positive social networks can
promote psychological adjustment through consistent
positive interactions and exchange of benefits. Support
is often conceptualized in terms of one’s social network
structure or the functions provided by its members (Tay-
lor, 2007). Structure relates to one’s social network and
linkages within a community, and is characterized by
the type, number, and strength of connections (Wills &
Ainette, 2012). Functional social support can be divided
into two primary types: emotional (i.e., love, trust) and
instrumental (i.e., tangible aid, services) (Cohen&Wills,
1985; House, Umberson, & Landis, 1988).
Numerous researchers have documented the relation-
ship between social support and depression (Aneshensel
& Frerichs, 1982; Aneshensel & Stone, 1982; George, Bla-
zer, Hughes, & Fowler, 1989; Lin & Dean, 1984). While
HIV researchers have conceptualized depression as med-
iating the relationship between social support and ART
treatment adherence (Gonzalez et al., 2004; Simoni,
Frick, Lockhart, & Liebovitz, 2002) the potential role of
social support as amoderator on the relationship between
depression and ART adherence remains underexplored.
The moderating role of social support is theoretically
grounded in network literature, which suggests that func-
tional social networks are dynamic over time (Cohen,
Mermelstein, Kamarck, & Hoberman, 1985) and the buf-
fering hypothesis of social support, which suggests that
supportive social networks attenuate negative symptoms
associated with stress (Cohen & Wills, 1985). This
relationship holds particular promise for intervention
development in the context of new technologies, as social
networks have the potential to promote health via social
media and other online platforms (Young et al., 2014).
While there is an understanding that social support
can work to promote medication adherence among
people living with HIV, interventions aimed at utilizing
social networks to improve adherence have been mixed
(Remien et al., 2005; Simoni et al., 2009; Simoni, Panta-
lone, Plummer, & Huang, 2007). More information is
needed on the relationships between depression, social
support and ART adherence. This study aims to examine
social network correlates of HIV medication adherence
in order to identify specific intervention targets. We
sought to answer the following: What is the structure
of HIV-positive MSM of color’s social networks; what
network variables are associated with improved medi-
cation adherence; and does having a social network
member who reminds participants to take their medi-
cation moderate the relationship between depression
and adherence?
Methods
Procedures
Participants were 18 years of age or older, English or
Spanish speakers, and identified as HIV-positive cisgen-
der men. To recruit eligible participants within the
greater Los Angeles area, we conducted outreach within
AIDS service organizations and support groups as well as
posted flyers in coffee shops, bars, clubs, and other social
venues. In addition, we relied on email advertisement
through a registry of HIV-positive individualskept by
the University of California, Los Angeles. Interested par-
ticipants called our project office for screening by the
study coordinator. Eligible participants were scheduled
for an interview at a location of their choice. Two
types of data collection strategies were employed to
gather information: a computer assisted survey and an
interviewer administered social network interview. The
surveys were completed on a study computer and lasted
15–20 min. Research assistants were available during this
time to answer questions. Participants then completed a
30-minute social network interview facilitated by the
research assistant using an iPad as has been done pre-
viously (Rice, 2010). Participants were paid $20 each as
incentive. Data collection occurred from November
2013 to June 2014. All protocols were approved byUni-
versity of California, Los Angeles.
Measures
Demographic characteristics
Included: age, race/ethnicity, sexual orientation, highest
educational attainment, current employment, relation-
ship status, and AIDS diagnosis.
Depressive symptoms
Assessed using the 10-item CES-D (Andresen, Mal-
mgren, Carter, & Patrick, 1994), participants were
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asked how they felt or behaved during the previous seven
days, with responses ranging from 0 = rarely or none of
the time (less than 1 day) to 3 = all of the time (5–7
days). Scores ranged from 0 to 30, with higher sum
scores suggesting greater depressive symptoms. In a
study examining the reliability and validity of the 10-
item CES-D among HIV-positive patients enrolled in a
drug treatment program in British Columbia, Canada,
the internal reliability was 0.88 (Zhang et al., 2012).
Cronbach’s alpha for this study was 0.83. CES-D 10
scores were dichotomized using a sum score of 10 or
higher to indicate the presence significant depressive
symptoms and nine or less to indicate no presence of sig-
nificant depressive symptoms (Andresen et al., 1994;
Zhang et al., 2012).
Social support
Utilizing social network interview methodology, infor-
mation was gathered regarding social network size, den-
sity, relationship type, communication frequency,
method of communication, emotional vs. instrumental
support, and other characteristics (e.g., known HIV sta-
tus of members, HIV disclosure to members). Network
characteristics were dichotomized to reflect whether a
participant had a least one network member who fit a
certain described characteristic (e.g., has at least one per-
son who reminds them to take their HIV medications:
Yes/No) and used in the univariate analysis because
the proportions of each type of network member were
skewed (Valente, 2010).
Treatment adherence
Adherence questions were adopted from the AIDS Clini-
cal Trials Group (ACTG) Adherence Baseline Question-
naire (Reynolds et al., 2004). Participants were asked
about the last time they missed their HIV medication.
Those who indicated ever missing their HIV medication
were asked a subsequent series of questions regarding
how often they missed taking their medications due to
various reasons. Standardized scores were constructed
by summing the 14 items, dividing this sum by the lar-
gest total possible, and multiplying by 100 as has been
done previously (Reynolds et al., 2004). Thus, scores
can range from 0 to 100, with higher scores indicating
greater adherence. Internal reliability for this study was
the same as for the original study (Cronbach’s alpha =
0.89).
Data analysis
Chi square, Wilcoxon-Mann-Whitney, and Spearman
correlation tests were performed to examine univariate
associations between treatment adherence and individ-
ual and network characteristics. Significant univariate
results were included in the subsequent multivariable
regression analysis. A multiplicative term was used in
ordinary least squares regression to test the moderating
effect of having at least one network member who
reminded the participant about taking HIV medications
on the relationship between depression and treatment
adherence, while controlling for potential confounders
(i.e., age, race/ethnicity and network size). All tests
were performed at the 5% significance level using SAS
9.4.
Results
Recruitment efforts resulted in 188 phone calls received
by potential participants, the study team contacting and
screening 94% (n = 176). Of those, 98% (n = 172) met eli-
gibility criteria. And of those, 85% (n = 146) completed
data collection. Reasons for non-participation included:
no-shows and not returning a maximum of three calls
following missed appointments. Study team members
Table 1. Participant characteristics (N = 150).
Characteristic
N (%) or mean
(SD) Range
Age (years) 45.98 (10.13) 20–71
Less than 30 years of age 10 (6.67)
Race/Ethnicity
White 21 (14.00)
Black 45 (30.00)
Other or mixed racea 6 (4.00)
Latino 78 (52.00)
Sexual Orientation
Heterosexual/straight 20 (13.51)
Homosexual/gay 107 (72.30)
Bisexual 21 (14.19)
Sexual behavior in the last 12 months
Sex with only men 112 (74.67)
Sex with only women 11 (7.33)
Sex with both men and women 9 (6.00)
Has not had sex 18 (12.00)
Men who have sex with men (MSM) 136 (90.67)
Highest educational attainment
9th grade or less 21 (14.00)
10th grade/11th grade 22 (14.67)
12th grade (high school diploma) 35 (23.33)
More than high school 72 (48.00)
Language in which survey was completed
English 110 (73.33)
Spanish 40 (26.67)
Currently employedb 29 (19.46)
Ever married 35 (23.97)
Currently not married nor living with a
partner
126 (84.56)
Attends a support group 90 (60.40)
AIDS Diagnosis 82 (55.41)
Ever skipped taking HIV medication 95 (65.52)
ACTG adherence score (α = 0.89) 71.88 (21.19) 11.90–100
CES-D 10 score (α = 0.83) 12.17 (6.51) 0–26
Presence of significant depressive
symptomsc
90 (60.40)
aIncludes Asian and Native American.
bIncludes part- and full-time employment.
cHaving a CES-D 10 score of 10 or higher.
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received four additional referrals on-site at community-
based organizations, resulting in a final sample of 150
HIV-positive MSM.
The average age of men in the sample was 46 years
(SD = 10.13, range = 20–71). More than half self-ident-
ified as Latino (52.00%), 30.00% as Black, 14.00%
White, and 4.00% as other or mixed race (e.g., Asian,
Native American). Based on sexual behavior in the last
12 months and sexual orientation, the majority of par-
ticipants were classified as MSM (90.67%). Nearly
three-quarters had at least a high school education
(71.33%). However, less than a quarter currently held
any part- or full-time employment (19.46%). More
than a quarter completed the survey in Spanish
(26.67%); just over half had received an AIDS diagnosis
(55.41%). The mean CES-D score was 12.17 (SD = 6.51,
range = 0–26), with 60.40% of the sample reporting a
score of 10 or greater. Nearly two-thirds indicated
“ever skipped taking HIV medication” (65.52%). The
average ACTG adherence score was 71.88 (SD = 21.19,
range = 11.90–100). See Table 1 for additional partici-
pant characteristics.
The mean network size was 9.91 (SD = 6.53, range =
1–33), and the mean network density was 0.34 (SD =
0.21, range = 0–0.89). In the last month, participants
spent time with about two-thirds of their social network
in-person (67.98%) and communicated with more than
half at least once a week (58.20%). Participants used
their phones to speak with nearly two-thirds (64.41%)
of their social network in the last month (including
video chat services, such as Skype) and to write to
more than a third (40.43%) of their social network
Table 2. Characteristics of participants’ networks (N = 150).
Mean
(SD)
Mean proportion
(SD) Range
Network size 9.91 (6.53) 1–33
Network density 0.34 (0.21) 0–0.88
Average age (years) 44.39 (7.64) 23.00–67.00
Relationship length (years) 12.76 (8.33) 0.01–44.00
Relationship type
Friend 0.68 (0.31) 0.00–1.00
Caseworker/social worker/therapist/agency staff 0.18 (0.19) 0.00–1.00
Doctor or nurse 0.08 (0.10) 0.00–0.67
Clergy member 0.03 (0.10) 0.00–0.67
Romantic partner 0.08 (0.14) 0.00–1.00
Family member
Sibling 0.10 (0.14) 0.00–1.00
Parent 0.03 (0.07) 0.00–0.33
Child 0.006 (0.03) 0.00–0.25
Extended family member 0.06 (0.10) 0.00–0.50
Acquaintance 0.05 (0.12) 0.00–0.67
Co-worker 0.02 (0.06) 0.00–0.35
HIV-positive 0.28 (0.24) 0.00–1.00
Lesbian, gay or bisexual 0.46 (0.30) 0.00–1.00
Disclosed HIV status to 0.82 (0.29) 0.00–1.00
Actively hid HIV status from 0.13 (0.24) 0.00–1.00
In last month:
Spent time with in person 0.68 (0.31) 0.00–1.00
Talked using the phonea 0.64 (0.32) 0.00–1.00
Communicated via writing using the phoneb 0.40 (0.36) 0.00–1.00
Talked with over the computerc 0.12 (0.26) 0.00–1.00
Communicated via writing using the computerd 0.24 (0.34) 0.00–1.00
Communicates with at least once a week 0.58 (0.30) 0.00–1.00
Emotional support
Makes feel liked or loved 0.60 (0.34) 0.00–1.00
Makes feel respected or admired 0.64 (0.35) 0.00–1.00
Would agree with actions or thoughts 0.56 (0.36) 0.00–1.00
Would confide in 0.55 (0.33) 0.00–1.00
Would go to for advice about a problem 0.51 (0.34) 0.00–1.00
Would tell if disagreed with actions or thoughts 0.54 (0.35) 0.00–1.00
Instrumental support
Reminds about taking HIV Medication 0.19 (0.28) 0.00–1.00
Has ever taken to doctor or other HIV-related appointment 0.12 (0.19) 0.00–1.00
Would help with housework, cooking, or groceries if needed 0.32 (0.28) 0.00–1.00
Would lend $100 for immediate help 0.30 (0.28) 0.00–1.00
Would help care for children and/or pets if needed 0.25 (0.26) 0.00–1.00
Would provide support if confined to bed for several weeks 0.44 (0.32) 0.00–1.00
aIncludes FaceTime, voice-to-voice.
bIncludes Facebook, chat rooms, dating sites, e-mail, text.
cIncludes Skype, video chat.
dIncludes Facebook, chat rooms, dating sites, e-mail.
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members (e.g., texting, Facebook, email). Participants
also used computers to speak with (11.65%) and write
to (24.47%) individuals in their social networks (Table 2).
More than two-thirds of participants’ social networks
were comprised of friends (68.33%); 18.05% were case-
workers, social workers, or therapists; 7.70% were
doctors or nurses; 3.12% were members of the partici-
pant’s religious community; and 7.52% were romantic
partners. Family made up smaller proportions of partici-
pants’ social networks compared to other relationship
types (9.57% siblings, 5.83% extended family members,
3.45% parents, 0.60% children). Participants reported
that 28.10% of their social networks members were
HIV-positive and that half were lesbian, gay, or bisexual
(45.94%). Additionally, participants disclosed their HIV
status to more than three-quarters of their social net-
works (81.53%), but actively hid their status from
12.81% (Table 2).
Table 3 provides the results from the univariate ana-
lyses. Older age (30 years of age or older), Black race/eth-
nicity, and greater depressive symptoms (higher CES-D
10 scores) were associated with worse adherence (lower
ACTG scores). No direct univariate associations were
found between the proportion of each network member
type and ACTG adherence score.
Figure 1 illustrates the moderating effect of having at
least one network member who reminded the participant
to take his HIV medications on the relationship between
depression and treatment adherence; Table 4 highlights
results from the multivariable regression analysis.
Although network size was not significant in the univari-
ate analyses, it was included in the final model to account
for varying network sizes among participants, which ran-
ged from 1 to 33. Controlling for covariates, adherence
scores among younger participants were 23.55 points
higher on average (p < 0.05) than older participants
(>30 years). Black participants had adherence scores
that were 9.09 points lower on average compared to par-
ticipants of other racial/ethnic groups (p < 0.05). Among
those who did not have at least one individual in their
social network to remind them to take their HIV medi-
cation, each one-unit increase in the depression score
was associated with a 1.61-point reduction in the treat-
ment adherence score (p < 0.05). After controlling for
age, race/ethnicity and network size, there was a signifi-
cant interaction effect between depressive symptoms and
having at least one network member who reminded the
participant about taking HIV medication (p < 0.05).
That is, the difference in treatment adherence scores
between those with and without network support for
medication adherence becomes 1.31 points greater with
each one-unit increase in depression scores on average
(p < 0.05).
Discussion
This study sought to understand the structure of HIV-
positive men’s social networks and its impact on the
relationship between depression and ART adherence.
Our sample was predominantly comprised of MSM of
color, a population with significant “drop offs” at each
step in the HIV treatment cascade (Centers for Disease
Control and Prevention, 2012). In Los Angeles County,
the most recent data on the HIV continuum of care indi-
cates that 47% of Black MSM and 51% of Latino MSM
achieve viral suppression, compared to 57% of White
and 58% Asian MSM (Rock Wohl, 2015). Our findings
provide key insights for the development of adherence
interventions for HIV-positiveMSMof color, a key target
population for reducing HIV-related health disparities
Table 3. Univariate associations between ACTG adherence score
and participant characteristics (N = 150).
Characteristic r or mean (SD) p-value
Age (years) 0.13 0.2015
Less than 30 years of age* 0.0259
Yes 88.89 (12.11)
No 70.74 (21.22)
Race/Ethnicity
White 81.29 (18.51) 0.0579
African American/Black* 65.95 (20.09) 0.0225
other or mixed racea 68.57 (25.44) 0.3932
Hispanic 73.70 (21.62) 0.3275
Men who have sex with men (MSM) 0.9248
Yes 71.92 (20.91)
No 71.43 (25.14)
Highest educational attainment 0.1476
Less than a high school education 65.96 (23.85)
High school education or more 74.19 (19.76)
Language in which survey was completed 0.8438
English 71.75 (24.21)
Spanish 71.90 (20.75)
Currently employedb 0.2865
Yes 77.50 (15.13)
No 70.39 (22.36)
Ever married 0.2115
Yes 76.53 (20.50)
No 70.22 (21.50)
Currently not married but living with a partner 0.0655
Yes 61.90 (24.27)
No 73.66 (20.14)
Attends a support group 0.3063
Yes 74.51 (18.77)
No 68.64 (24.02)
AIDS diagnosis 0.2772
Yes 73.57 (21.89)
No 70.03 (20.49)
CES-D 10 score (α = 0.83)* −0.29 0.0035
Presence of significant depressive symptomsc 0.1758
Yes 69.82 (21.39)
No 75.63 (20.60)
Overall social support score (α = 0.95) 0.16 0.1238
Family social support score (α = 0.93) 0.11 0.2877
Friend social support score (α = 0.94) 0.16 0.1230
Significant other social support score (α = 0.90) 0.15 0.1476
Network size 0.13 0.1937
Network density 0.08 0.4339
aIncludes Asian and Native American.
bIncludes part- and full-time employment.
cHaving a CES-D 10 score of 10 or higher.
*p < 0.05.
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(The White House, 2015) and contribute to a growing
body of literature on the role of social networks, mental
health, and technology in the lives of HIV-positive people
(Horvath et al., 2012; Horvath, Alemu, Danh, Baker, &
Carrico, 2016; K. J. Horvath et al., 2013; Muessig, Nek-
kanti, Bauermeister, Bull, & Hightow-Weidman, 2015).
As reflected by treatment adherence scores, nearly
two thirds of the men in our study reported missing
doses of their HIV medication. Skipping doses of ART
can have serious negative consequences at the individual
and community level. For individuals, missed doses can
lead to drug resistance and treatment failure (Bangsberg
et al., 2001; Sethi, Celentano, Gange, Moore, & Gallant,
2003); in addition, spikes in viral load have been linked
to greater odds of forward transmission (McNabb
et al., 2001). There are a range of interventions aimed
at improving ART adherence (Simoni, Pearson, Panta-
lone, Marks, & Crepaz, 2006), some of which are tailored
specifically for MSM (Horvath et al., 2013). However,
few of these interventions have been tailored specifically
for MSM of color, a population for whom HIV incidence
continues to rise (Centers for Disease Control and
Prevention, 2010; Centers forDiseaseControl and Pre-
vention, 2008). Our results indicate that Black partici-
pants had worse treatment adherence compared to
participants of other racial/ethnic groups. These findings
underscore the need for ART adherence interventions
that are culturally-tailored and strategically deployed to
engage Black MSM.
Adherence becomes especially complicated with HIV-
positive individuals who have depressive symptoms. A
meta-analysis focused on patients who were given pre-
ventive- or treatment-related medical recommendations
by a physician for a severe chronic condition (e.g., can-
cer, end-stage renal disease, angina, renal transplant,
breast cancer, or rheumatoid arthritis) found that par-
ticipants with depression were three times less likely to
be 100% adherent compared to non-depressed partici-
pants (DiMatteo, Lepper, & Croghan, 2000). In our
sample, depression was negatively associated with medi-
cation adherence. There are several explanations for this
finding. Depression can interfere with the tasks required
to remain engaged in the HIV Continuum of Care. For
example, those patients suffering from comorbid
depression may have difficulty mobilizing the resources
necessary to schedule and keep HIV-related medical
appointments, fill and refill prescriptions, and remember
to take medications. A range of interventions for HIV-
positive people that address depression have been
implemented and evaluated with mixed success, including
interventions that contain psychological, physical, and
HIV-specific components (Sherr, Clucas, Harding, Sibley,
& Catalan, 2011). Providers treating HIV-positive patients
should regularly screen for depression (Panel on Antire-
troviral Guidelines for Adults and Adolescents, 2016),
assess for stigma about receiving mental health services,
and make referrals to mental health providers. Integrating
mental health and HIV treatment can be helpful in coor-
dinating care and addressing barriers to adherence.
Our findings of the positive moderating influence that
having a supportive network member who reminded
participants to take their HIV medication had on the
relationship between depression and treatment adher-
ence underscores the importance of social support. Inter-
ventions, such as Directly Observed Therapy (DOT),
have been used to ensure that HIV-positive people take
their medications daily (Garvie et al., 2011; Gaur et al.,
2010). Some of these interventions include a social sup-
port component, which is linked with improved medi-
cation adherence (Simoni, Frick, & Huang, 2006);
however, many require paraprofessional support. Rely-
ing on peer-to-peer support for ART adherence in natu-
rally existing social networks may be a cost-effective way
of addressing treatment non-adherence among HIV-
positive MSM.
Figure 1. Moderating effect of having at least one network
member who reminds about taking HIV medication on the
relationship between depression and treatment adherence (N
= 96) .
Table 4. Multivariable regression analysis of depression on
treatment adherence (N = 96)^.
Characteristic b (SE) p-value
Intercept 99.76 (7.01)
Less than 30 years of age (ref = No)* 23.55 (8.27) 0.0055
Non-Hispanic African American/black (ref = No)* −9.09 (4.24) 0.0349
Network size −0.25 (0.28) 0.3735
CES-D 10 Score* −1.61 (0.42) 0.0003
Has at least one network member who reminds
about taking HIV medications (ref = No)*
−23.07 (8.92) 0.0113
Interaction between CES-D 10 Score and having
at least one network member who reminds
about taking HIV medications*
1.31 (0.63) 0.0394
*p < 0.05.
^Among those who reported ever missing taking their HIV medication.
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Technology has emerged as an important tool for the
treatment of HIV. In our study, participants communi-
cated with 64% of their network members by phone,
40% of their social network members via text, and 24%
of their network members via computer. These results
indicate important opportunities for technology-based
medication adherence support. A number of text-based
interventions that provide medication reminders have
been mounted (Dowshen, Kuhns, Johnson, Holoyda, &
Garofalo, 2012; Pop-Eleches et al., 2011). One social
media intervention used an interactive social media plat-
form to encourage medication adherence tracking
among HIV-positive men and was feasible and accepta-
ble to users (Horvath et al., 2013). With the increasing
importance of technology in everyday life, researchers
and practitioners should continue to explore the ways
in which new technologies may support medication
adherence among HIV-positive people. There may be
opportunities for linking HIV-positive patients with
depressive symptoms to technology-based interventions
that connect them to supportive network members
who can remind them to take their medications.
Limitations
All data relied on self-report, which may overestimate
ART adherence (McNabb et al., 2001). The ART adher-
ence scale may also underestimate nonadherence among
individuals who continuously miss taking their medi-
cation for a single reason and overestimate nonadher-
ence among those who do not miss taking their
medication as frequently but do so for several reasons.
Future studies should use more advanced methods of
adherence tracking, such as pill counting and biomarker
data on ART levels (Lehmann et al., 2014). Participants
were recruited from community-based agencies and a
registry of HIV-positive men interested in research,
which may explain the older mean age and substantial
percentage of participants with an AIDS diagnosis. As
the majority of new infections in the U.S. occur
among younger MSM, future research should use
methods to engage younger participants, including
recruiting online and through smartphone applications
(Holloway et al., 2014). Last, due to potential selection
bias, HIV-positive men who are most severely depressed
or those with low ART adherence may be under-
represented.
Conclusion
Despite limitations, this work advances research to
improve treatment adherence among MSM of color.
Depression is a common comorbid condition with
HIV diagnosis (Page-Shafer, Delorenze, Satariano, &
Winkelstein, 1996). HIV care providers should go
beyond routine depression screenings and medication
adherence referrals by including a more comprehensive
assessment of emotional and instrumental support
received through patients’ social networks. One such
resource is the presence of a supportive social network
member who can remind patients to take their medi-
cation and help problem solve barriers to adherence.
Our work demonstrates the importance of these sup-
portive network members for HIV-positive MSM with
depressive symptoms. Adherence reminders might
come in a variety of forms. The results presented
here indicate a range of technology use among HIV-
positive men. Further research should focus on ways
to harness social support via technology in the service
of sustained medication adherence for HIV-positive
MSM of color.
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